<bill session="115" type="h" number="3382" updated="2023-01-11T13:37:21Z">
  <state datetime="2017-07-25">REFERRED</state>
  <status>
    <introduced datetime="2017-07-25"/>
  </status>
  <introduced datetime="2017-07-25"/>
  <titles>
    <title type="display">YOUTH Act</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to better address substance use and substance use disorders among young people.</title>
    <title type="short" as="introduced">YOUTH Act</title>
    <title type="short" as="introduced">Youth Opioid Use Treatment Help Act of 2017</title>
  </titles>
  <sponsor bioguide_id="C001101"/>
  <cosponsors>
    <cosponsor bioguide_id="B001275" joined="2017-07-25"/>
  </cosponsors>
  <actions>
    <action datetime="2017-07-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-07-25" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-07-28">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="s" number="2055" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health personnel"/>
    <term name="Health programs administration and funding"/>
    <term name="Medical education"/>
  </subjects>
  <amendments/>
  <summary date="2018-05-09T20:59:22Z" status="Introduced in House">Youth Opioid Use Treatment Help Act of 2017 or the YOUTH Act

This bill amends the Public Health Service Act to expand the grant program for substance abuse treatment services for children and adolescents to cover young adults.

The Agency for Healthcare Research and Quality (AHRQ) must award grants for demonstration programs to: (1) expand access to medication-assisted treatment for opioid use disorders among adolescents and young adults, or (2) create and distribute resources on medication-assisted treatment training and implementation for health care providers of children, adolescents, and young adults.

 AHRQ must report on the demonstration programs and the availability of medication-assisted treatment for adolescents and young adults. The report must include recommendations for ensuring such treatment is accessible.</summary>
</bill>
